Implementation of Clinical Pathway to Improve Quality of Healthcare in Stroke Inpatients

• Conditions: Stroke

• Registration Number: NCT02978794
• Lead Sponsor: Changhua Christian Hospital

Brief Summary

With the extension of the average life expectancy, the incidence of cardiovascular diseases is also rising. Stroke in Taiwan has been the leading cause of morbidity and mortality, but also in countries around the world), stroke and the impact of socio-economic and health spending are large how to reduce the degree of disability after stroke is an important issue in medicine. For a long time, the resident will fill the clinical pathway form before the stroke inpatients were discharged. We also analyzed the data of clinical pathway every three months.

According to the current data of stroke clinical pathway included demographic data, length of hospitalization days, complications, functional independent measure, Brunnstrom motor recovery stage, mini-mental state examination, geriatric depression scale, blood pressure data, and post-stroke checklist for a retrospective analysis to provide more complete and more comprehensive information on follow-up care for stroke patients and effective use of medical resources, to improve the quality of future medical care and quality of life for stroke patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-11
• Study First Submitted: 2016-11-29
• Study First Submitted QC: 2016-11-29
• Study First Posted: 2016-12-01
• Status Verified: 2021-06
• Last Update Submitted: 2021-06-30
• Last Update Posted: 2021-07-01
• Primary Completion: 2022-02
• Study Completion: 2022-02

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Ischemic and hemorrhagic stroke patients
2. MRI confirmed the diagnosis of stroke
3. Within three months of onset of unilateral limb hemiplegia in patients

Exclusion Criteria

1. Initial tracheostomy impantation and hospital stay is less than 5 days
2. Combined with other neurological diseases, such as epilepsy, multiple neuropathy, Meniere's disease, vestibular neuritis, Parkinson's disease, dementia or cerebellar atrophy, etc.
3. Significant lesions of the lower limb joints, including joint contractures, lower limb fractures, joint replacement or long-term pain in patients with osteoarthritis
4. Unstable signs of life (if not through the tilt bed test) or severe cardiopulmonary disease
5. Those who can not cooperate with the study or who have not signed the inform consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
functional independent measurement	1 year
post-stroke checklist	1 year
Brunnstrom motor recovery stage	1 year